Animal models of human disease have been a tremendous asset to the development of cures for disease. Unfortunately, animal physiology is often not identical to human and more appropriate models are needed. Enter stem cell technology and tissue banking.
The culture of human cells, or xenotransplantation into mice with impaired immune responses provides a platform to test new drugs or culture protocols. To achieve this, an ongoing supply of human cells must be obtained and processed.
Kimera Labs sources human tissue and then processes it for research purposes.
Our group was born out of a tragedy millions of Americans are facing on a daily basis. Cancer.
Through fund raising, education, banking, research and distribution we have developed a number of tools to advance the state of health care in the oncology field.
Funding: By creating the Kimera Society Inc, we are developing a private operating foundation currently applying for 501(c)3 status with the IRS, allowing donors to target funds directly to research labs performing promising investigations.
Education: Kimera Labs and the Kimera Society supports the development of dotcure.org and cancerfocus.org.
Launched in 2006, cancerfocus.org is a patient education site and forum which allows our scientists to come directly into contact with patients that need the most concrete information available. Dotcure.org is a new intiative of the Kimera Society to crowd source research funds.
Banking: By soliciting tissues from cancer centers around the world, we are building a library of disease tissues to facilitate new drug discovery and testing in the future. Our pioneering work in cord blood banking, will bring new discoveries and uses to the rich and under-utilized cord blood cell industry.
Research: Through ongoing collaborations with the University of Miami, Johns Hopkins and other research centers, we participate in research projects for academic publications.
Distribution: As promising therapies and drugs are developed, we aid in the distribution of materials through our network of South American pharmacies and clinics.
http://kimeralabs.com/
Duncan Ross, PhD. has started a tumor immunotherapy service out of his lab in Miami. When anyone gets a biopsy or surgical tumor removed, they overnight it to him and then he tries to extract the T-cells and grow them against their tumors and reinject. He is working within an ambulatory center there with two surgeons.
Animal models of human disease have been a tremendous asset to the development of cures for disease. Unfortunately, animal physiology is often not identical to human and more appropriate models are needed. Enter stem cell technology and tissue banking.
Antigen and Lymphopenia-Driven Donor T-Cells
http://cancerfocus.org/forum/showthread.php?t=4015
Threaded Mode